Psychedelic Stock Review

Cybin (CYBN) Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using...

October 26, 2021 07:30 AM Eastern Daylight Time TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics,...

Ehave (EHVVF) Announces Inclusion in the 2021 Psychedelic Investor Guide

MIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental...

MindMed (MNMD) IPO on Nasdaq: Becomes Second Public Psychedelic Company.

InvestmentU By Amber Deter Apr 27, 2021 at 12:55PM The MindMed IPO is making waves in the news. It will be the second psychedelics company to go public...
Ehave, Psychedelic Stock Review

Report: Ehave Inc (EHVVF) Our Favorite Psychedelic Company

WE LOOKED FAR AND WIDE TO FIND OUR FAVORITE What exactly is a favorite? First what it isn’t. In early August our research team conducted...

Huge News at Ehave Inc.(EHVVF), our Favorite Psychedelic.

We just finished compiling the 2021 Psychedelic Investor Guide and reviewed 44 companies - in all shapes and sizes. Excluding Johnson & Johnson at...

Cybin (CLXPF CYBN) Banks $30 Million Overnight.

Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Common Shares. LIVE QUOTE TORONTO, July 28, 2021--(BUSINESS WIRE)--Cybin Inc. (NEO: CYBN) (OTCQB:...
Marcus Capone, Psychedelic Stock Review

Incredible Ibogaine Psychedelic’s Testimonial

TIME MAGAZINEIn 2013, Marcus retired from the military. But life as a civilian only made his depression, anger, headaches, anxiety, alcoholism, impulsivity and violent...
Psychedelic Stock Review

Are Psychedelics the New Prozac?

Amidst a national epidemic of opioid abuse, and suicides the need for new therapeutics has gained greater urgency. In it's first step to meet this...
cybin

Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright.

Advancing Multiple Psychedelics in Multiple Indications; Initiating With a Buy and $8 Price Target. REPORT LIVE QUOTE INVESTOR DECK

Atai Life Sciences (ATAI) Founder Christian Angermayer Interview.(VIDEO)

Best Psychedelic related interview we've seen yet. Christian states, "I think ultimately, the total addressable market is 100% of the world population!" Wait, what? Is he suggesting...

Latest article

When Secure Communications is Absolutely Paramount to Mission Success.

Sekur (SWISF) $0.05 Headed to Huge Special Ops Military Convention in Tampa FL. Will Demonstrate it's "SekurVoice" Solution, to Special Ops Buyers, Designed for...

Cabaletta (CABA) Surges 44% on Massive Volume Spike.

Biotech 12 Pack Off to Nice Start.. Cabaletta up 35%, GeoVax up 75%, and Replimune up 62%. All since late April! Biotech Stock Review is...

GeoVax (GOVX) Surges 51% on Massive Volume Spike.

MonkeyPox and Gedeptin Related News Spark New Investor Interest. MARKET BRIEF On a quiet Wednesday afternoon, the 29th, while we were nearing completion of an updated...